Skip to main content

RHUMBLINE ADVISERS

Position in FENC — Fennec Pharmaceuticals Inc.

CIK 1115418 BOSTON, MA

Position in FENC

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$375,916
+$183,434 QoQ
Shares Held
34,969
+11.7% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 104 holders
Holding Since
Jun 2020
17 quarters on record
Voting authority Sole 22% Shared 0% None 78%

Common Shares in FENC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. FENC ranks #204 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FENC

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $375,916 34,969
2026-03-31 $192,482 31,298
2025-12-31 $223,592 29,038
2025-09-30 $313,765 33,522
2025-06-30 $281,345 33,897
2025-03-31 $203,186 33,364
2024-12-31 $216,769 34,299
2024-09-30 $151,940 30,388
2024-06-30 $177,862 29,110
2024-03-31 $223,767 20,123
2023-12-31 $223,087 19,883
2023-09-30 $154,307 20,547
2023-06-30 $174,224 19,731
2021-03-31 $122,970 19,802
2020-12-31 $149,163 20,022
2020-09-30 $111,637 18,422
2020-06-30 $158,048 18,928